Related Experiment Videos

[Mechanism of troponin and CK-MB release after percutaneous coronary interventions]

Annalisa Mongiardo1, Alessandro Ferraro, Roberto Ceravolo

  • 1U.O. di Cardiologia Interventistica, Università degli Studi Magna Graecia, Catanzaro. indolfi@unicz.it

Insights

Cardiac troponin levels can increase after percutaneous coronary interventions, especially with stenting. Cardiac troponin I remains a specific marker for myocardial injury in these cases.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • Cardiac troponins are sensitive and specific biomarkers for detecting myocardial injury.
  • Elevated cardiac troponin occurs in 5-40% of patients post-percutaneous coronary interventions (PCI).
  • Troponin elevation is more common after stenting compared to balloon angioplasty alone.

Discussion:

  • Myocardial necrosis during angioplasty results from plaque embolization, side branch occlusion, intimal dissection, or temporary vessel occlusion.
  • Factors like complex lesions, diabetes, and plaque instability increase troponin elevation risk.
  • Prolonged procedure times in interventions and atherectomy can also cause myocardial necrosis.

Key Insights:

  • Minor troponin elevation is possible even after successful PCI.
  • Cardiac troponin I is a highly specific indicator of myocardial injury in the context of PCI.
  • Understanding these mechanisms aids in accurate patient assessment and risk stratification.

Outlook:

  • Further research into minimizing troponin release during PCI.
  • Developing strategies to differentiate procedural elevation from significant myocardial infarction.
  • Optimizing patient selection and procedural techniques to reduce cardiac troponin increase.

Related Concept Videos